![]() |
|||
PharmaceuticalsPharmaceutical policy plays a key role in the U.S. debate on health care. As "miracle drugs" have changed the nature of care in this country, costs to fill those prescriptions have risen considerably and elected officials continually hear from constituencies on the topics of price, increased research, assistance to fight a specific disease and so on. Jefferson Government Relations, LLC (Jefferson) team members have the unique experience needed to tackle this issue area - we have worked on pharmaceutical issues at the White House, at the Department of Health and Human Services and on the staffs of Congressional leaders with jurisdiction over health care and prescription drugs. We know and work closely with these decision makers, having decades of experience and serving as trusted advisors. The debate over how best to add a prescription drug benefit to Medicare will deeply impact the pharmaceutical industry. A reform of Average Wholesale Pricing could change the way pharmaceuticals are marketed and sold, reauthorization of the Food and Drug Administration in 2002 could re-open the Hatch-Waxman Act and bring about other changes in bringing pharmaceuticals to market, as well as the laws on Generics. It is a vital time in the pharmaceutical industry, and Jefferson's expertise in this field can help the meeting of your policy goals. Public policy participation also can play a role in a pharmaceutical company's marketing strategy. Political participation can build product and company presence and reach, while at the same time driving regulations that increase or decrease company expenses. Public policy can help to grow and protect products, assist in achieving product sales and other marketing objectives and embrace customers as allies within the public policy arena. At Jefferson we believe in an integrated public policy strategy that will deliver on multiple fronts for our clients. Jefferson's successes in this area include:
|